Literature DB >> 3214731

Postnatal development of parvalbumin-, calbindin- and adult GABA-immunoreactivity in two visual nuclei of zebra finches.

K Braun1, H Scheich, W Zuschratter, C W Heizmann, C Matute, P Streit.   

Abstract

The characterization of neuron populations by their immunoreactivity against parvalbumin- and calbindin (28-kDa)-antisera has been used to study the postnatal development of the visual diencephalic nucleus rotundus and the mesencephalic nucleus isthmi complex in zebra finches. In nucleus rotundus, parvalbumin-immunoreactivity was restricted to the neuropil during the first 10 days and appears additionally in somata around day 12 where it remains until adulthood. Calbindin-immunoreactivity of the very scarce neuropil and the few somata, which can be observed during the first two weeks, disappears until adulthood. Thus, the adult nucleus rotundus shows an almost complementary distribution of calbindin- and parvalbumin-immunoreactive structures: the numerous, heavily parvalbumin-positive somata, which are surrounded by dense immunoreactive neuropil are in sharp contrast to the complete absence of calbindin-immunoreactive somata. Only a thin rim surrounding this nucleus contains punctate calbindin-positive neuropil. In the nucleus isthmi complex, parvalbumin and calbindin staining patterns show markedly different developmental profiles. While the density of parvalbumin-immunoreactive neuropil in the parvocellular part of the nucleus isthmi continuously increases and the somata remain unstained, the initially heavily calbindin-positive somata gradually lose their immunoreactivity during the first two weeks. In the adult nucleus isthmi complex, parvalbumin- and calbindin show nearly identical staining patterns. A comparison between the two calcium-binding proteins and GABA-immunoreactivity in adult brains revealed different relationships in the two nuclei: while in nucleus rotundus GABA-staining pattern neither resembles that of parvalbumin nor of calbindin, in the nucleus isthmi complex all three staining patterns coincide.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3214731     DOI: 10.1016/0006-8993(88)90609-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Quantitative assessment of developing afferent patterns in the cat inferior colliculus revealed with calbindin immunohistochemistry and tract tracing methods.

Authors:  C K Henkel; M L Gabriele; J G McHaffie
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

Review 2.  Calcium-binding proteins: selective markers of nerve cells.

Authors:  C Andressen; I Blümcke; M R Celio
Journal:  Cell Tissue Res       Date:  1993-02       Impact factor: 5.249

3.  Appearance of parvalbumin-specific immunoreactivity in the cerebral cortex and hippocampus of the developing rat and gerbil brain.

Authors:  A Seto-Ohshima; E Aoki; R Semba; P C Emson; C W Heizmann
Journal:  Histochemistry       Date:  1990

4.  Modulation of perineuronal nets and parvalbumin with developmental song learning.

Authors:  Timothy S Balmer; Vanessa M Carels; Jillian L Frisch; Teresa A Nick
Journal:  J Neurosci       Date:  2009-10-14       Impact factor: 6.167

5.  Two classes of cortical GABA neurons defined by differential calcium binding protein immunoreactivities.

Authors:  S H Hendry; E G Jones; P C Emson; D E Lawson; C W Heizmann; P Streit
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

6.  Differential effects of long-term transplantation on the growth of cortical neurons containing parvalbumin or calbindin.

Authors:  K Gogelia; J Hámori
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

7.  Core and Shell Song Systems Unique to the Parrot Brain.

Authors:  Mukta Chakraborty; Solveig Walløe; Signe Nedergaard; Emma E Fridel; Torben Dabelsteen; Bente Pakkenberg; Mads F Bertelsen; Gerry M Dorrestein; Steven E Brauth; Sarah E Durand; Erich D Jarvis
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.